GI/Mage-tarmkreft
- Analkreft handlingsprogram
- Felles 001 Deksrazoksan, Savene
- Felles 003, 004, 084 Bevacizumab
- Felles 005 FLOX/bevacizumab
- Felles 006 FLIRI/bevacizumab
- Felles 011 Doksorubicin -7
- Felles 012, 013 Docetaksel -21
- Felles 014 Docetaksel -7, 30 mg/m2
- Felles 016 Docetaksel/karboplatin AUC5
- Felles 017 Doksorubicin liposomal
- Felles 019 FLIRI, fluorouracil/kalsiumfolinat/irinotekan
- Felles 020 FLOX, fluorouracil/kalsiumfolinat/oksaliplatin
- Felles 021 Irinotekan-21
- Felles 022 Karboplatin AUC5/pemetreksed
- Felles 023 Paklitaksel -7
- Felles 025 Trastuzumab iv 1. kur
- Felles 026 Trastuzumab iv 2. kur og senere
- Felles 027 Vinorelbin 25 mg/m2, dag 1 og 8
- Felles 028, 074, 075, 076 Zoledronsyre
- Felles 041 Nivolumab 3mg/kg
- Felles 042 EDP, Cisplatin/doksorubicin/etoposid
- Felles 046, 047 Fluorouracil/streptozocin
- Felles 048, 063 Pembrolizumab iv
- Felles 051 Cisplatin/pemetreksed
- Felles 053, 054, 139 Nivolumab iv
- Felles 056 HIPEC Mitomycin intraperitonealt
- Felles 057 HIPEC Karboplatin intraperitonealt
- Felles 064, 091 MK3475-158 Pembrolizumab
- Felles 069 Cetuksimab -14, 500 mg/m2
- Felles 080 Ipilimumab 1 mg/kg / nivolumab 3mg/kg
- Felles 082 Docetaksel -14
- Felles 089c BMS-986218 40mg / nivolumab 480mg CA022001 part 2C/2D
- Felles 092 Atezolizumab/bevacizumab
- Felles 131 Gemcitabine/karboplatin AUC5
- Felles 133 FOLFOX
- Felles 137 CHRO761A12101 Irinotekan ARM C
- Felles 138 CHRO761A12101 Tislelizumab ARM B
- Felles 146 Durvalumab – 28, pasient over 30 kg
- GI 008 FLIRI/cetuksimab 500 mg/m2
- GI 009 Irinotekan -14
- GI 011 FOLFIRI Fluorouracil/ kalsiumfolinat/irinotekan
- GI 012 FOLFIRINOX
- GI 013 FOLFOXIRI
- GI 016 CAPOX Kapecitabin/oksaliplatin
- GI 018 FLV Fluorouracil/kalsiumfolinat
- GI 020 FLV ved stråleterapi
- GI 021a Gemcitabin/kapecitabin
- GI 022abc Gemcitabin
- GI 023abc Gemcitabin/paklitakselalbumin -28 -21 -14
- GI 024 Panitumumab
- GI 029ab GEMOX
- GI 030 Fluorouracil dag 1-5/karboplatin AUC5
- GI 031 Fluorouracil infusor 120 timer/karboplatin AUC5
- GI 033 CiFu Cisplatin/fluorouracil d 1-4 anal-spiserør
- GI 034 CiFu Cisplatin 75 mg/m2 /fluorouracil infusor 96t
- GI 036 Cisplatin/fluorouracil/trastuzumab iv 1. kur
- GI 037 Cisplatin/fluorouracil/trastuzumab iv 2 kur +
- GI 038 Cisplatin/kapecitabin/trastuzumab iv, 1. kur
- GI 039 Cisplatin/kapecitabin/trastuzumab iv 2. kur+
- GI 042 Fluorouracil/oksaliplatin/ trastuzumab iv, 1. kur
- GI 043 Fluorouracil/oksaliplatin/trastuzumab iv, 2.kur +
- GI 044 FLIRI/panitumumab
- GI 045 Fluorouracil infusor 96 timer/oksaliplatin
- GI 048 CAPOX/trastuzumab iv, 1 kur
- GI 049 CAPOX/trastuzumab iv, 2. kur +
- GI 050 FLOT Docetaksel/fluorouracil/ kalsiumfolinat/oksaliplatin
- GI 054 Karboplatin AUC5/paklitaksel
- GI 067ab EP-GI cisplatin/etoposid
- GI 068abc EK-GI Etoposid/karboplatin AUC5
- GI 070a: Fluorouracil/streptozotocin, induksjonsbehandling
- GI 070b/071: Fluorouracil/streptozotocin, vedlikeholdsbehandling
- GI 072ab Cisplatin gemcitabin
- GI 086 Cetuksimab 500 mg/m2 /irinotekan
- GI 087 Cetuksimab/irinotekan - 21, 1 kur
- GI 088 Cetuksimab/irinotekan - 21, 2. kur og senere
- GI 089 Irinotekan/panitumumab
- GI 091 MiCap kapecitabin/mitomycin ved stråleterapi
- GI 112 FOLFIRI/Bevacizumab
- GI 114 FOLFIRI/cetuksimab 500 mg/m2
- GI 116 FOLFOX/panitumumab
- GI 129 mFOLFOX6, definitiv Kjemoradioterapi
- GI 133 FOLFIRINOX modifisert
- GI 153 FLOX, 5-FU/kalsiumfolinat/ oksaliplatin, METIMMOX
- GI 154 Nivolumab METIMMOX
- GI 155 FOLFIRI/panitumumab (5-FU/kalsiumfolinat/irinotek)
- GI 156, 157 Fluorouracil infusor 96 t/ oksaliplatin/trastuzumab
- GI 164 INCMGA 00012 Podium-studie
- GI 191 CORINTH Pembrolizumab 200 mg
- GI 192ab FOLFOX med trastuzumab
- GI 195 Cadd Solis Etoposid/karboplatin AUC5
- GI 196ab, 197, 198ab, 199ab CORINTH kjemo
- GI 200 CAPOX/bevacizumab -21
- GI 201 FLV/bevacizumab -14, 5 mg/kg
- GI 202 CiFu Cisplatin 60 mg/m2 /fluorouracil infusor
- GI 203 DCF-modifisert/ Cis/Doc/5-FU infusor 48t
- GI 204 TACE Doksorubicin Embozene Tandem
- GI 211ab SOx Oksaliplatin 100 og 130 mg/m2/S1 -21
- GI 212-217 Docetaksel/trastuzumab iv
- GI 220 NIPEC-OXA Oksaliplatin 130 mg/m2, intraperitonealt
- GI 223 EXCALIBUR Floksuridine
- GI 225a EXCALIBUR Heparin uten floksuridine
- GI 225b EXCALIBUR Deksametason heparin uten floksuridine
- GI 230 PelvEx II CAPOX kapecitabin/oksaliplatin
- GI 231 PelvEx II FOLFOX fluorouracil/leukov/oksaliplatin
- GI 232 PelvEx II FOLFIRI fluorouracil/leukovon/irinotekan
- GI 233 EVIDENT Gemcitabin
- GI 234-235 EVIDENT Cetuksimab
- GI 236-237 EVIDENT Pertuzumab/trastuzumab iv
- GI 239 EVIDENT Metotreksat
- GI 243 FOLFOX/bevacizumab
- GI 244 CAPOX/Nivolumab
- GI 245 FOLFOX/Nivolumab
- GI 246, 247 TACE Doksorubicin mikrosfærer LifePearl 75/150 mg
- GI 250b METIMMOX-2 Nivolumab
- GI 251 FLV/cetuksimab
- GI 252 CAPOX/pembrolizumab
- GI 253ab FOLFOX/pembrolizumab
- GI 258 FLV/panitumumab
- GI 266 METIMMOX-2 FLOX
- GI 267 KEYMAKER-06B Paklitaksel
- GI 268 KEYMAKER-06B Irinotekan
- GI 270-271 FLOX/trastuzumab
- GI 272 MOUNTAINEER-03 FOLFOX
- GI 273ab MOUNTAINEER-03 Trastuzumab
- GI 274 MOUNTAINEER-03 Bevacizumab -14
- GI 275ab MOUNTAINEER-03 Cetuksimab
- GI 281-282 AZUR-2 Dostarlimab
- GI 283 AZUR-2 CAPOX Kapecitabin/oksaliplatin
- GI 284 AZUR-2 FOLFOX Fluorouracil/oksaliplatin
- GI 285/286 Trastuzumab-14 (1. og senere kur)
- GI 288 TOMCAT Floksuridine
- GI 289a TOMCAT Heparin, uten floksuridine
- GI 289b TOMCAT Deksametason/heparin, uten floksuridine
- GI 290 Cisplatin/durvalumab/ gemcitabin, pas. over 30 kg
- GI 291ab KEYMAKER-06B MK-2870
- GI 292 ARTEMIDE-Biliary01 Rilvegostomig/placebo
- GI 293ab Tislelizumab
- GI 294 KEYMAKER-06D arm 1 Ramucirumab/paklitaksel
- GI 295ab KEYMAKER-06D arm 2 MK-2870/paklitaksel
- GI 296 KEYMAKER-06C arm 1 CAPOX/pembrolizumab
- GI 297 KEYMAKER-06C arm 1 FOLFOX/pembrolizumab
- GI 298 KEYMAKER-06C arm 2 Kapecitabin/MK-2870/pembro
- GI 299 KEYMAKER-06C arm 2 FLV/MK-2870/pembro
- GI 300 FLOX/Nivolumab
- GI 301-303 CRUKD/24/002 Ginisortamab/gemcitabin/paklitakselalbumin
- GI 304 Durvalumab/tremelimumab, pasient over 30 kg
- GI 305 CiFu-tislelizumab infusor 80/4000 120 timer
- GI 306 CAPOX/tislelizumab
- GI 307 Cetuksimab 1. kur
- GI 308 Cetuksimab 2. kur og senere
- GI 309 OPTIMISE, FOLFOXIRI
- GI 310 OPTIMISE, 5-FU monoterapi
- GI 311abc PSEUDOVAX
- GI 312abcd EMBOLD GSK5764227
- GI 313 DESTINY-G M1 Fluorour/pembro/trastuz.derukstekan
- GI 314 DESTINY-G M1 Kapecit/pembro/trastuz.derukstekan
- GI 315ab DESTINY-G M2 Cispl/fluorour/pembro/trastuzumab
- GI 316ab DESTINY-G M2 Fluorour/oksali/pembro/trastuzumab
- GI 317ab DESTINY-G M2 Cispl/kapecit/pembro/trastuzumab
- GI 318ab DESTINY-G M2 Kapecit/oksali/pembro/trastuzumab
- GI 319 DESTINY-G E1 Fluorour/trastuzumabderukstekan
- GI 320 DESTINY-G E1 Kapecitabin/tratuzumabderukstekan
- GI 321ab DESTINY-G E2 Cisplatin/fluorouracil/trastuzumab
- GI 322ab DESTINY-G E2 Fluorouracil/oksaliplatin/trastuzumab
- GI 323ab DESTINY-G E2 Cisplatin/kapecitabin/trastuzumab
- GI 324ab DESTINY-G E2 Kapecitabin/oksaliplatin/trastuzumab
- GI 325 FOLFOX/ cetuksimab/enkorafenib
- GI 326 KEYMAKER-06E Pembrolizumab-21
- GI 327abc KEYMAKER-06E Ifinatamabderuksikan/pembro
- GI 328 KEYMAKER-06E FOLFOX -14
- GI 329 KEYMAKER-06E FLV-14
- GI 330 KEYMAKER-06E Oksaliplatin/fluorouracil-14
- GI 331a: Streptozocin, induksjonsbehandling
- GI 331b: Streptozocin, vedlikeholdsbehandling
- GI 332 SIRI Irinotekan/S1 -21
- GI 333 Bevacizumab/S1 -21
- GI 336 Studie DSEE-CRC FLOX
- GI 337 Studie DSEE-CRC FLIRI
- GI 338 Studie DSEE-CRC FLV
- GI 339 Studie DSEE-CRC FLOT
- GI 340 Studie DSEE-CRC Bevacizumab 5mg/kg
- GI 341 Studie DSEE-CRC Panitumumab
- GI 342 Studie DSEE-CRC Cetuksimab 500 mg/m2
- GI 343 Studie DSEE-CRC Cetuksimab, 1 kur
- GI 344 Studie DSEE-CRC Cetuksimab, 2. kur og senere
- GI 345 Studie DSEE-CRC Oksaliplatin 130 mg/m2
- GI 346-347 Studie DSEE-CRC Docetaksel
- GI 348-349 Studie DSEE-CRC Trastuzumab iv
- GI 350 Studie DSEE-CRC Gemcitabin
- GI 351 Studie DSEE-CRC Metotreksat
- GI 352 Studie DSEE-CRC Epirubicin 40 mg
- GI 353 Studie DSEE-CRC Irinotekan
- GI 354 Studie DSEE-CRC Paklitaksel
- Mage-tarm 020 FLV ved stråleterapi
- Mage-tarm 021a GEMCAP Gemcitabin/kapecitabin
- Mage-tarm 021b Gemcitabin/kapecitabin redusert
- Mage-tarm 021b Gemcitabin/kapecitabin redusert
- Mage-tarm 032 Karboplatin AUC2/paklitaksel
- Mage-tarm 035 Cifu infusor 120t uten stråleterapi
- Mage-tarm 055/132a/132b MiFu Fluorouracil/mitomycin ved strålebehandling
- Mage-tarm 238 EVIDENT Pembrolizumab -21
- Mage-tarm 287 CiFu-nivolumab infusor 80/4000 120 timer
- Mage-tarm 334 Ipilimumab 1 mg/kg/nivolumab 240 mg
